Try our beta test site
45 studies found for:    Open Studies | "Meningitis"
Show Display Options
Rank Status Study
21 Not yet recruiting A Prospective Household Observational Cohort Study of Influenza, Respiratory Syncytial Virus and Other Respiratory Pathogens Community Burden and Transmission Dynamics in South Africa
Condition: Infective Organism Causing Respiratory Diseaseand Meningitis
Intervention:
22 Recruiting Penetration of Ceftaroline Into Cerebrospinal Fluid(CSF)
Conditions: Meningitis;   Ventriculitis
Intervention: Drug: Ceftaroline fosamil
23 Recruiting Postmarketing Surveillance Study for Use of Menactra® in the Republic of Korea
Conditions: Meningitis;   Meningococcal Meningitis;   Meningococcal Infections
Intervention: Biological: Meningococcal (Groups A, C, Y and W 135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine
24 Recruiting Surveillance of Hospitalised Pneumonia and Bacterial Meningitis in Tône District, Togo, 2010-2013
Conditions: Pneumonia, Bacterial;   Pneumonia, Viral;   Meningitis, Bacterial
Intervention:
25 Not yet recruiting Reduced PCV Dosing Schedules in South African Infants
Conditions: Pneumonia;   Meningitis
Interventions: Biological: Pneumococcal conjugate vaccine (PCV10 ) 1+1, 6 weeks;   Biological: Pneumococcal conjugate vaccine (PCV10 ) 1+1, 14 weeks;   Biological: Pneumococcal conjugate vaccine (PCV10 ) 2+1;   Biological: Pneumococcal conjugate vaccine (PCV13 ) 1+1, 6 weeks;   Biological: Pneumococcal conjugate vaccine (PCV13 ) 1+1, 14 weeks;   Biological: Pneumococcal conjugate vaccine (PCV13 ) 2+1
26 Recruiting Safety of a Meningococcal (Groups A, C, Y and W-135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine in Healthy Subjects in Vietnam
Conditions: Meningitis;   Meningococcal Meningitis;   Meningococcal Infections
Intervention: Biological: Meningococcal (Groups A, C, Y and W-135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine
27 Recruiting Immunogenicity and Safety of Meningococcal Groups A and C and Haemophilus b Conjugate Vaccine in Infants 2 to 5 Months of Age
Conditions: Meningitis;   Meningococcal Meningitis;   Meningococcal Infections
Interventions: Biological: Meningococcal Groups A and C and Haemophilus b Conjugate Vaccine (adjuvant-free);   Biological: Meningococcal Groups A and C and Haemophilus b Conjugate Vaccine(adjuvant)
28 Recruiting Etiology, Pathogenesis, and Natural History of Idiopathic CD4+ Lymphocytopenia
Conditions: Idiopathic CD4+ Lymphocytopenia;   Cryptococcal Meningitis;   Warts
Intervention:
29 Not yet recruiting Vietnam Cryptococcal Retention in Care Study
Conditions: Meningitis, Cryptococcal;   Central Nervous System Fungal Infections;   Central Nervous System Infections;   Meningitis, Fungal
Intervention: Drug: Fluconazole
30 Recruiting Early-Onset Sepsis an NICHD/CDC Surveillance Study
Conditions: Infant, Newborn, Diseases;   Early Onset Neonatal Sepsis;   Early-Onset Meningitis
Intervention:
31 Recruiting Auditory Brainstem Implantation in Young Children
Conditions: Developmental Cochlear Nerve Deficiency;   Acquired Cochlear Nerve Deficiency;   Cochlear Aplasia;   Post-meningitis Cochlear Ossification;   Cochlear Malformation
Intervention: Device: Auditory Brainstem Implantation in Children
32 Recruiting A Safety Study of the Auditory Brainstem Implant for Pediatric Profoundly Deaf Patients
Conditions: Profound Bilateral Deafness Due to;   Bilateral Cochlear Aplasia;   Bilateral Cochlear Nerve Deficiency;   Bilateral Cochlear Ossification Secondary to Meningitis
Intervention: Device: Auditory Brainstem Implant
33 Recruiting Optimizing Treatment to Improve TBM Outcomes in Children
Condition: Tuberculosis, Meningeal
Interventions: Drug: High-dose: RIF, INH, PZA, EMB;   Drug: High dose: RIF, INH, PZA, LEVO;   Drug: Standard of care: RIF, INH, PZA, EMB
34 Recruiting Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care
Conditions: Adenovirus;   Adrenal Insufficiency;   Airway Swelling;   Anesthesia;   Anxiety;   Anxiolysis;   Autism;   Autistic Disorder;   Bacterial Meningitis;   Bacterial Septicemia;   Benzodiazepine;   Bipolar Disorder;   Bone and Joint Infections;   Brain Swelling;   Central Nervous System Infections;   Convulsions;   Cytomegalovirus Retinitis;   Early-onset Schizophrenia Spectrum Disorders;   Edema;   Epilepsy;   General Anesthesia;   Gynecologic Infections;   Headaches;   Herpes Simplex Virus;   Hypertension;   Infantile Hemangioma;   Infection;   Inflammation;   Inflammatory Conditions;   Influenza;   Intra-abdominal Infections;   Lower Respiratory Tract Infections;   Migraines;   Pain;   Pneumonia;   Prophylaxis;   Schizophrenia;   Sedation;   Seizures;   Skeletal Muscle Spasms;   Skin and Skin-structure Infections;   Stable Angina;   Thromboprophylaxis;   Thrombosis;   Treatment-resistant Schizophrenia;   Urinary Tract Infection;   Withdrawal
Intervention: Drug: The POPS study is collecting PK data on children prescribed the following drugs of interest per standard of care:
35 Recruiting Fosfomycin i.v. for Treatment of Severely Infected Patients
Conditions: Bacterial Infections;   Bone Diseases, Infectious;   Osteomyelitis;   Central Nervous System Bacterial Infections;   Meningitis, Bacterial;   Encephalitis;   Brain Abscess;   Urinary Tract Infections;   Respiratory Tract Infections;   Pneumonia, Bacterial;   Skin Diseases, Bacterial;   Soft Tissue Infections;   Intraabdominal Infections;   Sepsis;   Bacteremia;   Endocarditis, Bacterial
Intervention:
36 Recruiting Hypovitaminosis D in Neurocritical Patients
Conditions: Craniocerebral Trauma;   Intracranial Aneurysm;   Brain Neoplasms;   Spinal Cord Injuries;   Seizures;   Meningitis;   Stroke;   Intracranial Hemorrhages;   Critical Illness;   Vitamin d Deficiency
Interventions: Drug: Cholecalciferol;   Other: Placebo
37 Recruiting Systematic Search for Primary Immunodeficiency in Adults With Infections
Conditions: Complement Deficiency;   Antibody Deficiency;   Chronic Sinus Infection;   Meningitis, Bacterial;   Pneumonia, Bacterial;   Otitis Media;   Streptococcal Infection;   Neisseria Infections;   Haemophilus Influenza;   Pneumococcal Infections
Intervention: Biological: Immunological diagnosis tests
38 Not yet recruiting Study to Assess the Immunological Long-term Persistence of Antibodies (Abs) 2 Years After GlaxoSmithKline (GSK) Meningococcal ABCWY Vaccination in the V102_15 (NCT02212457) and Response to a Booster in Adolescents
Condition: Infections, Meningococcal
Interventions: Biological: Meningococcal ABCWY Vaccine;   Biological: Meningococcal B Recombinant vaccine
39 Recruiting Study to Assess the Safety and Immunogenicity of a Single Dose of GlaxoSmithKline's (GSK) Meningococcal MenACWY-CRM Vaccine (Menveo), Administered to Subjects 15 Through 55 Years of Age, Approximately 4-6 Years After Primary ACWY Vaccination
Condition: Infections, Meningococcal
Intervention: Biological: Meningococcal (groups A, C, W and Y) oligosaccharide diphtheria CRM-197 conjugate Vaccine (Menveo)
40 Recruiting Community Acquired Bacteremic Syndromes in Young Nigerian Children
Condition: Community-Acquired Infections
Intervention:

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-45) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.